Viewing Study NCT05423834


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT05423834
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-02-08
First Post: 2022-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir
Sponsor: Chinese University of Hong Kong
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-21
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-13
First Submit QC Date: None
Study First Post Date: 2022-06-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-06
Last Update Post Date: 2023-02-08
Last Update Post Date Type: ACTUAL